149 related articles for article (PubMed ID: 20701957)
41. Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.
Ukaji T; Lin Y; Banno K; Okada S; Umezawa K
PLoS One; 2015; 10(9):e0137663. PubMed ID: 26360832
[TBL] [Abstract][Full Text] [Related]
42. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
[TBL] [Abstract][Full Text] [Related]
43. Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: cytoplasmic sequestration of CDK2 by p27.
Itamochi H; Yoshida T; Walker CL; Bartholomeusz C; Aoki D; Ishihara H; Suzuki N; Kigawa J; Terakawa N; Ueno NT
Gynecol Oncol; 2011 Sep; 122(3):641-7. PubMed ID: 21652059
[TBL] [Abstract][Full Text] [Related]
44. Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.
Suzuki S; Shibata K; Kikkawa F; Nakatsura T
Hum Vaccin Immunother; 2014; 10(2):338-43. PubMed ID: 24252799
[TBL] [Abstract][Full Text] [Related]
45. Glypican-3 expression in clear cell adenocarcinoma of the ovary.
Maeda D; Ota S; Takazawa Y; Aburatani H; Nakagawa S; Yano T; Taketani Y; Kodama T; Fukayama M
Mod Pathol; 2009 Jun; 22(6):824-32. PubMed ID: 19329941
[TBL] [Abstract][Full Text] [Related]
46. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways.
Buchanan C; Stigliano I; Garay-Malpartida HM; Rodrigues Gomes L; Puricelli L; Sogayar MC; Bal de Kier Joffé E; Peters MG
Breast Cancer Res Treat; 2010 Feb; 119(3):559-74. PubMed ID: 19288189
[TBL] [Abstract][Full Text] [Related]
47. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line].
Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309
[TBL] [Abstract][Full Text] [Related]
48. Cytokine gene expression signature in ovarian clear cell carcinoma.
Yanaihara N; Anglesio MS; Ochiai K; Hirata Y; Saito M; Nagata C; Iida Y; Takakura S; Yamada K; Tanaka T; Okamoto A
Int J Oncol; 2012 Sep; 41(3):1094-100. PubMed ID: 22751940
[TBL] [Abstract][Full Text] [Related]
49. GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.
Luo C; Shibata K; Suzuki S; Kajiyama H; Senga T; Koya Y; Daimon M; Yamashita M; Kikkawa F
Oncol Rep; 2014 Sep; 32(3):913-21. PubMed ID: 24992906
[TBL] [Abstract][Full Text] [Related]
50. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
Anglesio MS; Carey MS; Köbel M; Mackay H; Huntsman DG;
Gynecol Oncol; 2011 May; 121(2):407-15. PubMed ID: 21276610
[TBL] [Abstract][Full Text] [Related]
51. Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.
Cho HS; Ahn JM; Han HJ; Cho JY
J Cell Biochem; 2010 Dec; 111(5):1252-9. PubMed ID: 20803547
[TBL] [Abstract][Full Text] [Related]
52. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
[TBL] [Abstract][Full Text] [Related]
53. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
[TBL] [Abstract][Full Text] [Related]
54. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
[TBL] [Abstract][Full Text] [Related]
55. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
56. [The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].
Aoki D; Komiyama S; Susumu N; Nozawa S
Nihon Rinsho; 2001 Jan; 59 Suppl 1():213-6. PubMed ID: 11235169
[No Abstract] [Full Text] [Related]
57. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
58. GPC3 reduces cell proliferation in renal carcinoma cell lines.
Valsechi MC; Oliveira AB; Conceição AL; Stuqui B; Candido NM; Provazzi PJ; de Araújo LF; Silva WA; Calmon Mde F; Rahal P
BMC Cancer; 2014 Aug; 14():631. PubMed ID: 25168166
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
Itamochi H; Oumi N; Oishi T; Taniguchi F; Shoji T; Fujiwara H; Sugiyama T; Suzuki M; Kigawa J; Harada T
Int J Gynecol Cancer; 2015 May; 25(4):570-6. PubMed ID: 25756405
[TBL] [Abstract][Full Text] [Related]
60. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
